INJ Targets $42+: Buyer Strength Signals

28. Jan.

Analyzing Injective Protocol (INJ) on higher timeframes reveals a significant lateral consolidation, with the price currently near the lower boundary of this range. Following the global correction, there's a noticeable increase in buying strength, suggesting a bullish outlook. I anticipate an upward movement, targeting levels above $42, primarily because there are substantial liquidations above these levels. This could trigger a liquidity hunt, driving the price further up as buyers aim to capitalize on these liquidation points.